Clinical Trial Update: Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating a Group B streptococcal vaccine for safety and immunogenicity in non-pregnant and pregnant women aged 18-40. The study has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection

Drugs mentioned

• Group B streptococcal vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Streptococcal Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-05